Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma

Summary Missing in metastasis (MIM) proteins are important regulators in controlling cell growth and development. There has been accumulating evidence suggesting a role of MIM-B in carcinogenesis, yet its role in the development of hepatocellular carcinoma has not been examined thus far. In this stu...

Full description

Saved in:
Bibliographic Details
Published inHuman pathology Vol. 38; no. 8; pp. 1201 - 1206
Main Authors Ma, Stephanie, MSc, Guan, Xin-Yuan, PhD, Lee, Terence K., PhD, Chan, Kwok Wah, MBBS
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.2007
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Missing in metastasis (MIM) proteins are important regulators in controlling cell growth and development. There has been accumulating evidence suggesting a role of MIM-B in carcinogenesis, yet its role in the development of hepatocellular carcinoma has not been examined thus far. In this study, we investigated the clinicopathological significance of MIM-B in tumor and its matched adjacent nontumor tissue obtained from 40 patients with hepatocellular carcinoma. Increased MIM-B messenger RNA and protein expression, as detected by quantitative real-time polymerase chain reaction and Western blot, respectively, was found in hepatocellular carcinoma clinical samples; and its expression was significantly associated with early pathologic tumor-node-metastasis stage group ( P = .007), presence of tumor encapsulation ( P = .034), and absence of venous infiltration ( P = .038). Higher levels of MIM-B expression were found to be associated with early stage disease. Elevated MIM-B expression may influence the development of hepatocellular carcinoma and may possibly be a powerful indicator for the disease at an early stage.
ISSN:0046-8177
1532-8392
DOI:10.1016/j.humpath.2007.01.004